Related Experiment Videos
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction
William Y Ho1, Joseph N Blattman, Michelle L Dossett
1Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, USA.
Cancer Cell
|June 5, 2003
Abstract:
Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.